{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:50:34Z","timestamp":1774263034961,"version":"3.50.1"},"reference-count":119,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1016\/j.canrad.2004.12.005","type":"journal-article","created":{"date-parts":[[2005,1,26]],"date-time":"2005-01-26T00:35:23Z","timestamp":1106699723000},"page":"55-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Les carcinomes du nasopharynx : de la biologie \u00e0 la clinique"],"prefix":"10.1016","volume":"9","author":[{"given":"S.","family":"Rivera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Keryer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Busson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Maingon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2004.12.005_bib1","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1038\/sj.onc.1206402","article-title":"Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies","volume":"22","author":"Abdulkarim","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.canrad.2004.12.005_bib2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/jso.2930330310","article-title":"Distant metastases of nasopharyngeal carcinoma. A study of 256 male patients","volume":"33","author":"Ahmad","year":"1986","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.canrad.2004.12.005_bib3","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1200\/JCO.1998.16.4.1310","article-title":"Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099","volume":"16","author":"Al-Sarraf","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2004.12.005_bib4","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1023\/A:1008255220284","article-title":"Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer","volume":"9","author":"Au","year":"1998","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canrad.2004.12.005_bib5","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jnci\/82.7.616","article-title":"High complete response in advanced nasopharyngeal carcinoma with bleomycin, epirubicin and cisplatin before radiotherapy","volume":"82","author":"Bachouchi","year":"1990","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canrad.2004.12.005_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/path.867","article-title":"Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: comparison with Hodgkin's disease","volume":"194","author":"Beck","year":"2001","journal-title":"J. Pathol."},{"key":"10.1016\/j.canrad.2004.12.005_bib7","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1002\/1097-0142(19800601)45:11<2725::AID-CNCR2820451105>3.0.CO;2-1","article-title":"Analysis of failure after definitive irradiation for epidermoid carcinoma of the nasopharynx","volume":"45","author":"Bedwinek","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib8","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/0360-3016(89)90970-X","article-title":"Proton therapy for carcinoma of the nasopharynx: a study in comparative treatment planning","volume":"16","author":"Brown","year":"1989","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canrad.2004.12.005_bib9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ijc.2910420422","article-title":"Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas","volume":"42","author":"Busson","year":"1988","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.tim.2004.06.005","article-title":"EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies","volume":"12","author":"Busson","year":"2004","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.canrad.2004.12.005_bib11","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1003::AID-CNCR1>3.0.CO;2-F","article-title":"The role of chemotherapy in the management of nasopharyngeal carcinoma","volume":"82","author":"Chan","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib12","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2002.08.149","article-title":"Concurrent chemotherapy-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial","volume":"20","author":"Chan","year":"2002","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2004.12.005_bib13","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0360-3016(96)00416-6","article-title":"The role of brachytherapy in early-stage nasopharyngeal carcinoma","volume":"36","author":"Chang","year":"1996","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canrad.2004.12.005_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2559.2004.01935.x","article-title":"Nasopharyngeal intraepithelial lesion: latent Epstein-Barr virus infection with malignant potential","volume":"45","author":"Cheung","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.canrad.2004.12.005_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/1097-0142(19940115)73:2<247::AID-CNCR2820730203>3.0.CO;2-7","article-title":"A phase II study of outpatient chemotherapy with cisplatinium, 5-fluorouracil, and leucovorin in nasopharyngeal carcinoma","volume":"73","author":"Chi","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib16","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0360-3016(01)02781-X","article-title":"A phase III study of adjuvant chemotherapy in advanced stage nasopharyngeal carcinoma patients","volume":"52","author":"Chi","year":"2002","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canrad.2004.12.005_bib17","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0009-9260(96)80056-0","article-title":"Skull base erosion in nasopharyngeal carcinoma: detection by CT and MRI","volume":"51","author":"Chong","year":"1996","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.canrad.2004.12.005_bib18","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/1097-0142(19911115)68:10<2120::AID-CNCR2820681005>3.0.CO;2-7","article-title":"Chemotherapy for recurent or metastatic carcinoma of the nasopharynx: a review of the Princes Margaret hospital experience","volume":"68","author":"Choo","year":"1991","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib19","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/ijc.20079","article-title":"RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma","volume":"109","author":"Chow","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib20","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2003.10.038","article-title":"Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy","volume":"59","author":"Chua","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canrad.2004.12.005_bib21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/cncr.11485","article-title":"Treatment outcome after radiotherapy alone for patients with stage I-II nasopharyngeal carcinoma","volume":"98","author":"Chua","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib22","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1038\/sj.onc.1203656","article-title":"High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma","volume":"19","author":"Crook","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.canrad.2004.12.005_bib23","doi-asserted-by":"crossref","first-page":"195s","DOI":"10.1016\/S1278-3218(01)80029-9","article-title":"Carcinoma of the nasopharynx. Radiotherapy modalities and combined radiotherapy and chemotherapy: state of the art and perspectives","volume":"5","author":"Daoud","year":"2001","journal-title":"Cancer Radiother."},{"key":"10.1016\/j.canrad.2004.12.005_bib24","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/1097-0215(200102)9999:9999<::AID-IJC1177>3.0.CO;2-9","article-title":"Study of human leukocyte antigen class I phenotypes in Moroccan patients with nasopharyngeal carcinoma","volume":"92","author":"Dardari","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib25","first-page":"5584","article-title":"Expression of BARF1 gene encoded by Epstein-Barr virus in nasopharyngeal carcinoma biopsies","volume":"60","author":"Decaussin","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.canrad.2004.12.005_bib26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/ijc.2910420206","article-title":"Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study","volume":"42","author":"De Vathaire","year":"1988","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0065-230X(03)87296-2","article-title":"Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: new immunobiological and molecular insights on a long-standing etiopathogenic association","volume":"87","author":"Dolcetti","year":"2003","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.canrad.2004.12.005_bib28","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1158\/0008-5472.CAN-03-2196","article-title":"Induction of therapeutic T-cell responses to subdominant tumor-associated viral oncogene after immunization with replication-incompetent polyepitope adenovirus vaccine","volume":"64","author":"Duraiswamy","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canrad.2004.12.005_bib29","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1182\/blood-2002-10-3092","article-title":"Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma","volume":"101","author":"Duraiswamy","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.canrad.2004.12.005_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/viro.1999.9855","article-title":"Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains","volume":"261","author":"Edwards","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.canrad.2004.12.005_bib31","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/JVI.78.2.868-881.2004","article-title":"Potential selection of LMP1 variants in nasopharyngeal carcinoma","volume":"78","author":"Edwards","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.canrad.2004.12.005_bib32","first-page":"1937","article-title":"Use of preoperative MRI to predict dural, perineural and venous sinus invasion of skull base tumors","volume":"17","author":"Eisen","year":"1996","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.canrad.2004.12.005_bib33","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00000421-199310000-00011","article-title":"Nasopharyngeal brachytherapy","volume":"16","author":"Erickson","year":"1993","journal-title":"Am. J. Clin. Oncol."},{"issue":"suppl1","key":"10.1016\/j.canrad.2004.12.005_bib34","doi-asserted-by":"crossref","first-page":"189s","DOI":"10.1016\/S1278-3218(01)80028-7","article-title":"Carcinomes du nasopharynx: aspects cliniques, indications et r\u00e9sultats de la radioth\u00e9rapie transcutan\u00e9e et de la curieth\u00e9rapie. Etat de la question en 2001","volume":"5","author":"Eschw\u00e8ge","year":"2001","journal-title":"Cancer Radiother."},{"key":"10.1016\/j.canrad.2004.12.005_bib35","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00001622-200405000-00007","article-title":"Optimal management of nasopharyngeal carcinoma","volume":"16","author":"Faivre","year":"2004","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.canrad.2004.12.005_bib36","first-page":"382","article-title":"Nasopharyngeal cancer: epidemiology, staging and treatment","volume":"21","author":"Fandi","year":"1994","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.canrad.2004.12.005_bib37","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1200\/JCO.2000.18.6.1324","article-title":"Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type","volume":"18","author":"Fandi","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2004.12.005_bib38","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archotol.1991.01870230049006","article-title":"Long-terme survival after surgical resection for recurrent nasopharyngeal cancer after radotherapy failure","volume":"117","author":"Fee","year":"1991","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.canrad.2004.12.005_bib39","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng932","article-title":"Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4","volume":"31","author":"Feng","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canrad.2004.12.005_bib40","first-page":"1920","article-title":"Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors","volume":"62","author":"Feng","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canrad.2004.12.005_bib41","first-page":"273","article-title":"Evaluation de la r\u00e9ponse tumorale et ganglionnaire \u00e0 la chimioth\u00e9rapie n\u00e9o-adjuvante dans les carcinomes indiff\u00e9renci\u00e9s du nasopharynx","volume":"84","author":"Frikha","year":"1997","journal-title":"Bull. Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib42","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1148\/117.2.425","article-title":"Treatment of locally recurrent carcinoma of the nasopharynx","volume":"117","author":"Fu","year":"1975","journal-title":"Radiology"},{"key":"10.1016\/j.canrad.2004.12.005_bib43","first-page":"155","article-title":"Treatment of recurrent NPC by radiation therapy in head and neck cancer","volume":"3","author":"Goffinet","year":"1993","journal-title":"Amsterdam: Experta medica"},{"key":"10.1016\/j.canrad.2004.12.005_bib44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.radonc.2003.09.011","article-title":"CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG, consensus guidelines","volume":"69","author":"Gr\u00e9goire","year":"2003","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.canrad.2004.12.005_bib45","first-page":"865","article-title":"Nasopharyngeal carcinomas frequently lack the p16\/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product","volume":"152","author":"Gulley","year":"1998","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canrad.2004.12.005_bib46","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/path.1569","article-title":"Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma","volume":"203","author":"Heussinger","year":"2004","journal-title":"J. Pathol."},{"key":"10.1016\/j.canrad.2004.12.005_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2156-4-3","article-title":"Polymeric immunoglobulin receptor polymorphisms and risk of nasopharyngeal cancer","volume":"4","author":"Hirunsatit","year":"2003","journal-title":"BMC Genet."},{"key":"10.1016\/j.canrad.2004.12.005_bib48","first-page":"99","article-title":"Stage classification of nasopharyngeal carcinoma\u00a0: a review","volume":"20","author":"Ho","year":"1978","journal-title":"IARC Sci. Publ."},{"key":"10.1016\/j.canrad.2004.12.005_bib49","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cncr.20129","article-title":"Comparison of clinical and molecular surveillance in patients with advanced nasopharyngeal carcinoma after primary therapy: the potential role of quantitative analysis of circulating Epstein-Barr virus DNA","volume":"100","author":"Hong","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib50","unstructured":"Hu LFH. Q. Fu, S. Di, S. Magnusson, K. Ernberg, I. Possible linkage of susceptibility genes of nasopharyngeal carcinoma to chromosome 5. In: North-South Workshop on Nasopharyngeal Carcinoma; 2003; Institut Gustave Roussy, Villejuif, France."},{"key":"10.1016\/j.canrad.2004.12.005_bib51","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/0360-3016(85)90033-1","article-title":"Nasopharyngeal cancer\u00a0: study III. A review of 1206 patients treated with combined modalities","volume":"1","author":"Huang","year":"1985","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canrad.2004.12.005_bib52","first-page":"1599","article-title":"Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells","volume":"59","author":"Huang","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.canrad.2004.12.005_bib53","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/mc.10156","article-title":"Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma","volume":"38","author":"Hui","year":"2003","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.canrad.2004.12.005_bib54","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0360-3016(00)01389-4","article-title":"Treatment planning and delivery of intensity-modulatedradiation therapy for primary nasopharynx cancer","volume":"49","author":"Hunt","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2004.12.005_bib55","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0360-3016(96)80007-1","article-title":"Preliminary results of a randomized trial comparing neoadjuvant chemotherapy plus radiotherapy versus radiotherapy alone in stage IV (N2-N3 M0) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. VUMCA I trial","volume":"35","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2004.12.005_bib56","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0304-3835(02)00697-3","article-title":"Polymorphism of the stress protein HSP70-2 gene is associated with the susceptibility to the nasopharyngeal carcinoma","volume":"193","author":"Jalbout","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canrad.2004.12.005_bib57","first-page":"125","article-title":"Nasopharyngeal Carcinoma: An Epidemiological Approach to Carcinogensis","volume":"33","author":"Jeannel","year":"1999","journal-title":"Cancer Surv."},{"key":"10.1016\/j.canrad.2004.12.005_bib58","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/hed.10370","article-title":"Molecular characterization of Epstein-Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea","volume":"26","author":"Jeon","year":"2004","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2004.12.005_bib59","doi-asserted-by":"crossref","first-page":"531","DOI":"10.3109\/02841869309096113","article-title":"Prognostic factors in patients with nasopharyngeal carcinoma","volume":"32","author":"Kaasa","year":"1993","journal-title":"Acta Oncol."},{"key":"10.1016\/j.canrad.2004.12.005_bib60","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0360-3016(03)00075-0","article-title":"Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation","volume":"56","author":"Kam","year":"2003","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canrad.2004.12.005_bib61","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1177\/000348940010901209","article-title":"Comparision of 18-fluoro-2-deoxyglucose positron emission tomography and computed tomography in detectiion of cervical lymph node metastases of nasopharyngeal carcinoma","volume":"109","author":"Kao","year":"2000","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/j.canrad.2004.12.005_bib62","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0361-090X(03)00098-9","article-title":"Similar BCL-X but different BCL-2 levels in the two age groups of north African nasopharyngeal carcinomas","volume":"27","author":"Khabir","year":"2003","journal-title":"Cancer Detect. Prev."},{"key":"10.1016\/j.canrad.2004.12.005_bib63","first-page":"3932","article-title":"Contrasted frequencies of p53 accumulation in the two age groups of North African nasopharyngeal carcinomas","volume":"6","author":"Khabir","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canrad.2004.12.005_bib64","first-page":"310","article-title":"Molecular characterization of antigen-processing function in nasopharyngeal carcinoma (NPC): evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells","volume":"58","author":"Khanna","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.canrad.2004.12.005_bib65","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ijc.2910560207","article-title":"Identification of integrated Epstein-Barr virus in nasopharyngeal carcinoma using pulse field gel electrophoresis","volume":"56","author":"Kripalani-Joshi","year":"1994","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0360-3016(02)02724-4","article-title":"Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience","volume":"53","author":"Lee","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2004.12.005_bib67","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/0360-3016(91)90030-8","article-title":"Improved dose distributions for 3D conformal boost treatments in carcinoma of the nasopharynx","volume":"20","author":"Leibel","year":"1991","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canrad.2004.12.005_bib68","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.ymthe.2003.08.018","article-title":"Efficacy of targeted FasL in nasopharyngeal carcinoma","volume":"8","author":"Li","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.canrad.2004.12.005_bib69","first-page":"6952","article-title":"Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma","volume":"62","author":"Lin","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canrad.2004.12.005_bib70","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.2003.06.158","article-title":"Phase III study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival","volume":"21","author":"Lin","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2004.12.005_bib71","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1148\/radiology.213.2.r99nv29489","article-title":"Nasopharyngeal carcinoma: repeat treatment with conformal proton therapy dose volume histogram analysis","volume":"213","author":"Lin","year":"1999","journal-title":"Radiology"},{"key":"10.1016\/j.canrad.2004.12.005_bib72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1259\/bjr\/69516821","article-title":"False positive fluorine-18 fluorodeoxy-D-glucose positron emission tomography finding caused by osteoradionecrosis in a nasopharyngeal carcinoma patient","volume":"77","author":"Liu","year":"2004","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.canrad.2004.12.005_bib73","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ijc.11166","article-title":"Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma","volume":"106","author":"Liu","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib74","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1044579X02000883","article-title":"Genetic and epigenetic changes in nasopharyngeal carcinoma","volume":"12","author":"Lo","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canrad.2004.12.005_bib75","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/hed.10398","article-title":"Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in T1 and T2 nasopharyngeal carcinoma","volume":"26","author":"Lu","year":"2004","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2004.12.005_bib76","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0360-3016(03)01508-6","article-title":"Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma","volume":"58","author":"Lu","year":"2004","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canrad.2004.12.005_bib77","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/cncr.10995","article-title":"Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma","volume":"95","author":"Ma","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib78","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1200\/JCO.2001.19.5.1350","article-title":"Results of a prospective randomized trial comparing neoadjuvant chemotherapy plus radiotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma","volume":"19","author":"Ma","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2004.12.005_bib79","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000055353","article-title":"Association between HLA-A\/-B antigens and -DRB1 alleles and nasopharyngeal carcinoma in Tunisia","volume":"61","author":"Mokni-Baizig","year":"2001","journal-title":"Oncology"},{"key":"10.1016\/j.canrad.2004.12.005_bib80","first-page":"7875","article-title":"Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs","volume":"61","author":"Murono","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.canrad.2004.12.005_bib81","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/emboj\/21.5.954","article-title":"Epstein-Barr virus RNA confers resistance to interferon-alpha-induced apoptosis in Burkitt's lymphoma","volume":"21","author":"Nanbo","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.canrad.2004.12.005_bib82","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1001\/archotol.1989.01860350027010","article-title":"New staging system for nasopharyngeal carcinoma","volume":"115","author":"Neel","year":"1989","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.canrad.2004.12.005_bib83","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00259-004-1498-9","article-title":"Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET","volume":"31","author":"Ng","year":"2004","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.canrad.2004.12.005_bib84","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jviromet.2003.10.015","article-title":"Detection of wild type and deleted latent membrane protein 1 (LMP1) of Epstein-Barr virus in clinical biopsy material","volume":"116","author":"Nicholls","year":"2004","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.canrad.2004.12.005_bib85","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/(SICI)1096-9896(199710)183:2<164::AID-PATH919>3.0.CO;2-J","article-title":"The association of squamous cell carcinomas of the nasopharynx with Epstein-Barr virus shows geographical variation reminiscent of Burkitt's lymphoma","volume":"183","author":"Nicholls","year":"1997","journal-title":"J. Pathol."},{"key":"10.1016\/j.canrad.2004.12.005_bib86","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/ijc.1440","article-title":"Estimating the world cancer burden: Globocan 2000","volume":"94","author":"Parkin","year":"2001","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib87","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0360-3016(92)90741-Y","article-title":"Carcinoma of the nasopharynx\u00a0: Factors affecting prognosis","volume":"23","author":"Perez","year":"1992","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canrad.2004.12.005_bib88","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0360-3016(92)90792-G","article-title":"Retreatment of NPC in 53 patients","volume":"22","author":"Prizant","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2004.12.005_bib89","first-page":"589","article-title":"Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma","volume":"62","author":"Qian","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.canrad.2004.12.005_bib90","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/1097-0142(19880315)61:6<1117::AID-CNCR2820610611>3.0.CO;2-J","article-title":"Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation","volume":"61","author":"Qin","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib91","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1044579X0200086X","article-title":"Epstein-Barr virus in the pathogenesis of NPC","volume":"12","author":"Raab-Traub","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canrad.2004.12.005_bib92","series-title":"Conventional and array-based CGH analysis of Nasopharyngeal Carcinomas from the Mediterranean area : high frequency of gains at 1q and 12p and losses at 11q and 13q","author":"Rodriguez","year":"2005"},{"key":"10.1016\/j.canrad.2004.12.005_bib93","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1200\/JCO.1988.6.9.1401","article-title":"Adjuvant chemotherapy with vincristine, cyclophosphamide and doxorubicin after radiotherapy in local-regional nasopharyngeal cancer results of a 4-years multicenter randomized study","volume":"58","author":"Rossi","year":"1988","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canrad.2004.12.005_bib94","first-page":"924","article-title":"Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: opposite effects of CD95 and CD40 stimulation","volume":"59","author":"Sbih-Lammali","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.canrad.2004.12.005_bib95","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiology.216.2.r00au04371","article-title":"Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy-results of a prospective study","volume":"216","author":"Schaefer","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.canrad.2004.12.005_bib96","series-title":"Lemerle","first-page":"88","article-title":"Les carcinomes du nasopharynx: Etude anatomo-clinique, clinique, traitement, r\u00e9sultats","author":"Schwaab","year":"1993"},{"key":"10.1016\/j.canrad.2004.12.005_bib97","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1259\/0007-1285-63-747-202","article-title":"Nasopharyngeal carcinoma: pattern of skeletal metastases","volume":"63","author":"Sham","year":"1990","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.canrad.2004.12.005_bib98","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3349\/ymj.2004.45.1.100","article-title":"High dose 3-dimensional re-irradiation for locally recurrent nasopharyngeal cancer","volume":"29","author":"Shin","year":"2004","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.canrad.2004.12.005_bib99","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1259\/bjr.70.832.9166079","article-title":"Intracavitary radiotherapy boosting for nasopharyngeal cancer","volume":"70","author":"Slevin","year":"1997","journal-title":"Br. J. Radiol."},{"key":"10.1016\/j.canrad.2004.12.005_bib100","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000227179","article-title":"Chemotherapy with platin and continous infusion of 5-fluorouracil and bl\u00e9omycin for recurrent and metastatic nasopharyngeal carcinoma in Ta\u00efwan","volume":"50","author":"Su","year":"1993","journal-title":"Oncology"},{"key":"10.1016\/j.canrad.2004.12.005_bib101","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1101::AID-CNCR2>3.0.CO;2-R","article-title":"Phase II trial of chemotherapy with 5-fluorouracil, bleomycin, epirubicin and cisplatin for locally advanced and metastatic\/recurrent undifferenciated carcinoma of the nasopharynx type","volume":"86","author":"Taamma","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib102","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1053\/hupa.2001.20886","article-title":"A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages","volume":"32","author":"Tang","year":"2001","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canrad.2004.12.005_bib103","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S1044579X02000925","article-title":"Treatment strategy and clinical experience","volume":"12","author":"Teo","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canrad.2004.12.005_bib104","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0360-3016(99)00326-0","article-title":"Intracavitary brachytherapy significantly enhances local control of early T stage nasopharyngeal carcinoma: the existenceof a dose-tumor-control relationship above conventional tumoricidal dose","volume":"46","author":"Teo","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canrad.2004.12.005_bib105","series-title":"Classification of malignant tumors","first-page":"33","year":"2003"},{"key":"10.1016\/j.canrad.2004.12.005_bib106","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S1044579X02000901","article-title":"The significance of LMP1 expression in nasopharyngeal carcinoma","volume":"12","author":"Tsao","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canrad.2004.12.005_bib107","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/1097-0142(19900501)63:9<1668::AID-CNCR2820630903>3.0.CO;2-1","article-title":"Improved results in the treatment of nasopharyngeal carcinoma using combined radiotherapy and chemotherapy","volume":"63","author":"Tsuji","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib108","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/archotol.1988.01860150110026","article-title":"Salvage surgery for nasopharyngeal carcinoma","volume":"114","author":"Tu","year":"1988","journal-title":"Arch. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.canrad.2004.12.005_bib109","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/0360-3016(87)90030-7","article-title":"Re-irradiation of recurrent nasopharyngeal carcinoma treatment techniques and results","volume":"13","author":"Wang","year":"1987","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canrad.2004.12.005_bib110","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1002\/1097-0142(19890615)63:12<2461::AID-CNCR2820631217>3.0.CO;2-#","article-title":"Accelerated hyperfractionation radiation therapy for carcinoma of the nasopharynx. Techniques and results","volume":"63","author":"Wang","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib111","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0360-3016(00)01588-1","article-title":"Failure of 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma","volume":"49","author":"Wolden","year":"2001","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canrad.2004.12.005_bib112","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hed.10098","article-title":"Chemotherapy with or without radiotherapy in patients with locoregionally recurrent nasopharyngeal carcinoma","volume":"24","author":"Wong","year":"2002","journal-title":"Head Neck"},{"key":"10.1016\/j.canrad.2004.12.005_bib113","series-title":"WHO handbook for reporting results of cancer treatment","year":"1979"},{"key":"10.1016\/j.canrad.2004.12.005_bib114","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0360-3016(99)00304-1","article-title":"The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study","volume":"46","author":"Wu","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.canrad.2004.12.005_bib115","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1158\/0008-5472.CAN-03-3253","article-title":"A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma","volume":"64","author":"Xiong","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.canrad.2004.12.005_bib116","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/02841868309134335","article-title":"Radiation therapy of recurrent nasopharyngeal carcinoma: Report of 219 patients","volume":"22","author":"Yan","year":"1983","journal-title":"Acta Radiol. Oncol."},{"key":"10.1016\/j.canrad.2004.12.005_bib117","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/cncr.11519","article-title":"18-Fluoro-2-deoxyglucose positron emission tomography in detecting residual\/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging","volume":"98","author":"Yen","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2004.12.005_bib118","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1044579X02000858","article-title":"Epidemiology of nasopharyngeal carcinoma","volume":"12","author":"Yu","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.canrad.2004.12.005_bib119","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/(SICI)1096-9071(199807)55:3<227::AID-JMV8>3.0.CO;2-3","article-title":"Epstein-Barr virus expression within keratinizing nasopharyngeal carcinoma","volume":"55","author":"Zhang","year":"1998","journal-title":"J. Med. Virol."}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321804001386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321804001386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:11:54Z","timestamp":1761135114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321804001386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S1278321804001386"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2004.12.005","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les carcinomes du nasopharynx : de la biologie \u00e0 la clinique","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2004.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}